General
Preferred name
TRIAMCINOLONE ACETONIDE
Synonyms
Azmacort ()
Aristoderm ()
Aristogel ()
Adcortyl ()
Kenacourt ()
Triacort ()
Remiderm ()
NSC-21916 ()
Triacet ()
Oralone ()
Gppe Ear Dps Cap ()
Kenacort ()
Remotic ()
Kenalog In Orabase ()
Kenalog-H ()
Aureocort ()
Nasacort Aq ()
Aristocort ()
Triderm ()
Aristocort A ()
Nystadermal ()
Kenalog ()
Allernaze ()
Tri-Nasal ()
Nasacort Hfa ()
Nasacort allergy 24 hour ()
Kenalog-80 ()
Triatex ()
Trivaris ()
Gppe Ear Oint ()
Oracort ()
Triesence ()
Tri-Adcortyl ()
Xipere ()
Trymex ()
Triamcinolone Acetonide In Absorbase ()
FX006 ()
Flutex ()
FX-006 ()
Kenalog-10 ()
Audicort ()
Zilretta ()
Adcortyl In Orabase ()
Pevaryl T.C. ()
Nasacort ()
Vetalog ()
Kenalog-40 ()
Silderm ()
Triamcinolone acetonide-d7 ()
P&D ID
PD003160
CAS
76-25-5
13586-95-3
Tags
available
probe
drug
Approved by
FDA
First approval
1960
Drug Status
vet_approved
approved
Max Phase
4.0
Drug indication
Glucocorticoid
Probe info
Probe type
calculated probe
Probe targets
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Triamcinolone is a corticosteroid type anti-inflammatory drug. The approved drug often contains this formulation of the compound. The hexacetonide, furetonide and benetonide forms all have individual INNs. (GtoPdb)
DESCRIPTION The approved drug often contains this formulation of the compound.
Cell lines
1
Organisms
1
Compound Sets
17
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugCentral
DrugCentral Approved Drugs
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
NPC Screening Collection
Probe Miner (suitable probes)
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
59
Properties
(calculated by RDKit )
Molecular Weight
434.21
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
2
Rotatable Bonds
2
Ring Count
5
Aromatic Ring Count
0
cLogP
2.42
TPSA
93.06
Fraction CSP3
0.75
Chiral centers
8.0
Largest ring
6.0
QED
0.69
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Metabolism
Immunology/Inflammation
Protein Tyrosine Kinase/RTK
Vitamin D Related/Nuclear Receptor
Target
Glucocorticoid Receptor
NR3C1, SERPINA6
FGFR
Indication
corticosteroid-responsive dermatoses
MOA
glucocorticoid receptor agonist, immunosuppressant
Source data